{"database": "lobbying", "table": "lobbying_activities", "rows": [[3243016, "3330d236-72ee-43d9-aeaa-f30d435f26c7", "Q3", "TENAGRITY SOLUTIONS, LLC", 401107856, "KARDIOGENICS, INC.", 2024, "third_quarter", "MED", "Discussions with congressional offices and DoD re: client and how their product and work (including how they can help with defense); meetings with FDA officials re: approval for client's product", "Defense, Dept of (DOD),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2024-10-17T11:54:37-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3243016"], "units": {}, "query_ms": 0.40192599408328533, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}